LID

Top Performer: Huasun's Himalaya HJT Modules Have Passed Rigorous PVEL Reliability Testing

Retrieved on: 
Friday, June 2, 2023
PAN, PQP, PIB, Attention, Marketing, Le Cirque World's Top Performers, HJT, PID, LID, Renewable energy, Transformer

The report outlined that the Huasun Himalaya G12 series HJT modules passed the comprehensive reliability testing conducted by PVEL, earning the prize of "Top Performer" for their outstanding product reliability and excellent power-generation performance.

Key Points: 
  • The report outlined that the Huasun Himalaya G12 series HJT modules passed the comprehensive reliability testing conducted by PVEL, earning the prize of "Top Performer" for their outstanding product reliability and excellent power-generation performance.
  • As an acknowledgment of the comprehensiveness of the testing, PQP testing results are regarded as a crucial reference for investors and developers when selecting high-quality modules.
  • The Huasun Himalaya G12 series HJT modules, which were selected for testing, performed well in all six tests, with an average power degradation rate of 1.2%.
  • In practical applications, too, Himalaya G12 series HJT modules demonstrate lower power degradation and more stable performance than other types of photovoltaic modules.

Politan Calls on Shareholders to Elect Independent Oversight to Masimo’s Board

Retrieved on: 
Tuesday, May 23, 2023
Other Professional Services, Professional Services, Finance, Lead, Louisiana-Pacific, Employment, MPC, LPX, CNC, Marathon Petroleum, Policy, CAH, Immunity, Research, History, SET, J&J, Somatosensory system, Cardinal Health, Elon Musk, Midas, Acquisition, Investment, Hearing, Annual general meeting, Growth, Johnson & Johnson, Health, LID, NYSE, Behavior, Management, Pharmaceutical industry, Film industry, Security (finance), Property management, Masimo, Nicholas H. Politan

The bottom 2% for “withhold” votes against Board members: Over the past decade, Masimo shareholders have withheld against Masimo directors at consistently high levels.

Key Points: 
  • The bottom 2% for “withhold” votes against Board members: Over the past decade, Masimo shareholders have withheld against Masimo directors at consistently high levels.
  • Create Lead Independent Director (LID) role; yet appoint Mr. Cohen as LID: While we strongly support independent leadership of Masimo’s Board, Mr. Cohen is the wrong choice.
  • Michelle is currently an independent director at Cardinal Health (NYSE: CAH) and recently served on the Board of Coupa Software (NASDAQ: COUP).
  • By electing us, shareholders will be adding to the Board independent, objective directors with the right skills and experience to help the Company realize its potential.

InventHelp Inventor Develops Modified Pot Lid to Reduce Kitchen Odors (TLP-182)

Retrieved on: 
Thursday, May 25, 2023
Aurora, SCIENCE, Garlic, LID, Multimedia, POT, Cooking, Sale, Onion, Heating, ventilation, and air conditioning

PITTSBURGH, May 25, 2023 /PRNewswire/ -- "I wanted to create a kitchen tool to purify/filtrate food odors in the kitchen when cooking," said an inventor, from Aurora, Colo., "so I invented THE POT LID OF SCIENCE.

Key Points: 
  • PITTSBURGH, May 25, 2023 /PRNewswire/ -- "I wanted to create a kitchen tool to purify/filtrate food odors in the kitchen when cooking," said an inventor, from Aurora, Colo., "so I invented THE POT LID OF SCIENCE.
  • My design helps prevent unpleasant odors within the home, particularly when cooking with onions and garlic."
  • The patent-pending invention provides an effective means of eliminating unpleasant odors in the kitchen when cooking/frying foods on the stovetop.
  • In doing so, it prevents cooking odors from traveling throughout the house.

Premier Energies India certified as 'Top Performer' among global PV manufacturers by PVEL

Retrieved on: 
Wednesday, May 24, 2023
PAN, PQP, Light, Cell, PV, Marketing, Modularity, Le Cirque World's Top Performers, Engineering, PID, Solar cell, LID, Renewable energy

HYDERABAD, India, May 24, 2023 /PRNewswire/ -- Premier Energies Limited, India's 2nd largest integrated Solar cell and Module manufacturer has been recognised as 'Top performer' among global PV manufacturers in PVEL's 2023 PV module reliability score card.

Key Points: 
  • HYDERABAD, India, May 24, 2023 /PRNewswire/ -- Premier Energies Limited, India's 2nd largest integrated Solar cell and Module manufacturer has been recognised as 'Top performer' among global PV manufacturers in PVEL's 2023 PV module reliability score card.
  • Premier Energies, backed by global environment fund GEF Capital (based in Washington DC), has offices in India and Toronto and offers reliable, high performance Solar Cells and Modules worldwide.
  • The Company's state of the art, fully automated line in Hyderabad (India) has annual capacity of 2GW of cells and 3 GW of modules.
  • "We congratulate Premier Energies for achieving Top Performer status in the 2023 PV Module Reliability Scorecard," commented Tristan Erion-Lorico, VP of Sales and Marketing at PVEL.

ASTRO N7 - Astronergy new masterpiece, globally debuts at SNEC

Retrieved on: 
Wednesday, May 24, 2023
SNEC, BOS, ASTRO, Multimedia, Temperature, Cell, LCOE, PREC, Silicon, LID, Topcon, N5, Renewable energy

SHANGHAI, May 24, 2023 /PRNewswire/ -- Astronergy, a pioneer in n-type TOPCon PV modules, launched its newly upgraded ASTRO N n-type TOPCon products – ASTRO N7 at a grand ceremony held at the 2023 SNEC PV Power Expo in Shanghai, China, on May 24th, receiving the IEC Certificate from TÜV Rheinland.

Key Points: 
  • SHANGHAI, May 24, 2023 /PRNewswire/ -- Astronergy, a pioneer in n-type TOPCon PV modules, launched its newly upgraded ASTRO N n-type TOPCon products – ASTRO N7 at a grand ceremony held at the 2023 SNEC PV Power Expo in Shanghai, China, on May 24th, receiving the IEC Certificate from TÜV Rheinland.
  • To further improve PV products' performance and reliability, the new products are composed of rectangle silicon wafers with larger area than M10 182mm wafers ASTRO N5 products use before.
  • Same as previous ASTRO N series products, ASTRO N7 will have a least 12 years product warranty and 30 years power warranty.
  • The temperature coefficient of ASTRO N7 has been further optimized to -0.29%/℃.

ASTRO N7 - Astronergy new masterpiece, globally debuts at SNEC

Retrieved on: 
Wednesday, May 24, 2023
SNEC, BOS, ASTRO, Temperature, Cell, LCOE, PREC, IEC, Silicon, LID, Topcon, N5, Renewable energy

SHANGHAI, May 24, 2023 /PRNewswire/ -- Astronergy, a pioneer in n-type TOPCon PV modules, launched its newly upgraded ASTRO N n-type TOPCon products – ASTRO N7 at a grand ceremony held at the 2023 SNEC PV Power Expo in Shanghai, China, on May 24th, receiving the IEC Certificate from TÜV Rheinland.

Key Points: 
  • SHANGHAI, May 24, 2023 /PRNewswire/ -- Astronergy, a pioneer in n-type TOPCon PV modules, launched its newly upgraded ASTRO N n-type TOPCon products – ASTRO N7 at a grand ceremony held at the 2023 SNEC PV Power Expo in Shanghai, China, on May 24th, receiving the IEC Certificate from TÜV Rheinland.
  • To further improve PV products' performance and reliability, the new products are composed of rectangle silicon wafers with larger area than M10 182mm wafers ASTRO N5 products use before.
  • Same as previous ASTRO N series products, ASTRO N7 will have a least 12 years product warranty and 30 years power warranty.
  • The temperature coefficient of ASTRO N7 has been further optimized to -0.29%/℃.

Vikram Solar Continues to Win PVEL's Top Performer Position Six Times in Last Seven Years

Retrieved on: 
Tuesday, May 23, 2023
Sequence, Scorecard, PAN, PQP, BOM, MSS, Panel data, Marketing, Le Cirque World's Top Performers, Vikram Solar, PID, LID, Renewable energy

KOLKATA, India, May 23, 2023 /PRNewswire/ -- Vikram Solar, one of India's leading solar module manufacturers has been successful once again in claiming position of the 'Top Performer' in PVEL PV Module Reliability Scorecard 2023 by passing a rigorous PQP (Product Qualification Program) testing procedure. PVEL PQP is considered a virtual gold standard for module bankability across the solar industry. Vikram Solar's PARADEA Mono PERC 144 cell Bifacial Glass-Glass solar module, which has already been a hot favourite in the international market, appeared as top performer through PQP tests. Vikram Solar's stringent BOM selection criteria and robust process control on state of the art manufacturing lines have helped the company to consistently introduce top performer solar modules.

Key Points: 
  • PVEL PQP is considered a virtual gold standard for module bankability across the solar industry.
  • Vikram Solar's PARADEA Mono PERC 144 cell Bifacial Glass-Glass solar module, which has already been a hot favourite in the international market, appeared as top performer through PQP tests.
  • Vikram Solar's stringent BOM selection criteria and robust process control on state of the art manufacturing lines have helped the company to consistently introduce top performer solar modules.
  • We congratulate Vikram Solar on their sixth Scorecard appearance in demonstrating module reliability through PVEL's rigorous testing."

EQS-News: Innolux to Showcase High-Value, Cross-Domain, Sustainable Products and Technologies at SID Display Week 2023

Retrieved on: 
Monday, May 22, 2023
Paper, Digital photo frame, Marketing, Presence (album), Royal College of Emergency Medicine, SID, TFT-LCD, Pioneer, Digital technology, Module, WTSR, Integration, LID, Breakthrough, AR, Television, Professional corporation

MIAOLI, TAIWAN - Media OutReach - 22 May 2023 - Innolux is set to attend the SID Display Week 2023 (Booth# 313) in Los Angeles from May 23 to 25, 2023.

Key Points: 
  • MIAOLI, TAIWAN - Media OutReach - 22 May 2023 - Innolux is set to attend the SID Display Week 2023 (Booth# 313) in Los Angeles from May 23 to 25, 2023.
  • With the theme of "Make for Your Life," Innolux will exhibit a series of display technology applications in smart living.
  • Innolux's "Integrated automotive LID", the world's first-ever single-piece large curved display, is a front-seat display that maximizes information display.
  • Video featuring Innolux's SID products:
    Innolux SID 2023, Make For Your Life - Breakthrough Technologies:

PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine) for the Treatment of Parkinson’s Disease

Retrieved on: 
Tuesday, May 2, 2023
Diamond, Patent, Priority review, Communication, Motor disorder, CSE, Depression, Dyskinesia, New Drug Application, NDA, Accelerated approval (FDA), USD, NDMA, White Light Rock & Roll Review, Trial of the century, Movement, Pain, Hypertension, Plasma protein binding, Ketamine, Patient, Collection, Phase, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Levodopa-induced dyskinesia, LID, Food, Safety, Pharmaceutical industry

Filling an unmet medical need is defined as providing a therapy where none exists or providing a therapy which may be potentially better than available therapy.

Key Points: 
  • Filling an unmet medical need is defined as providing a therapy where none exists or providing a therapy which may be potentially better than available therapy.
  • NDA review usually does not begin until the drug company has submitted the entire application to the FDA.
  • Summary results of the Phase I/II clinical study:
    Enrolled subjects with moderate to advanced Parkinson’s disease with a target infusion rate being 0.30 mg/kg/hr.
  • Parkinson’s disease is a debilitating disorder that affects an estimated 1 million people in the U.S. and 10 million people worldwide.

PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease

Retrieved on: 
Wednesday, March 29, 2023
Diamond, Patent, Motor disorder, CSE, Depression, Dyskinesia, Marketing, Fast Track, Type, USD, NDMA, Movement, Trial of the century, Pain, Hypertension, Ketamine, Patient, Risk, Phase, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Levodopa-induced dyskinesia, LID, Food, Safety, Pharmaceutical industry, Medical imaging, Risk management

The Company will provide updates to its clinical development initiatives as they arise.

Key Points: 
  • The Company will provide updates to its clinical development initiatives as they arise.
  • Summary results of the Phase I/II clinical study:
    Enrolled subjects with moderate to advanced Parkinson’s disease with a target infusion rate being 0.30 mg/kg/hr.
  • The maximum tolerated infusion rate ranged from 0.20-0.30 mg/kg/hr, which was dependent on either discomfort due to dissociation or hypertension.
  • Parkinson’s disease is a debilitating disorder that affects an estimated 1 million people in the U.S. and 10 million people worldwide.